RUT058-60

· Pulmatrix Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RUT058-60, covering 2016-02-04 to 2016-02-04. Get the full timeline:

Most recent: Clinical Trial Update: 21 Day Cumulative Skin Irritation of RUT058-60 [Phase 1]